E-pharmacy retailer SastaSundar Ventures (SSVL) has delivered an outstanding performance since the start of the pandemic. Given the stellar show, there's every reason to believe that SastaSundar will continue to strengthen its foothold in the Indian online pharmacy market. The only problem is that the stock is now fairly valued, which leaves little margin of safety for new investors. Best ever sales in Q1 SSVL has seen revenues accelerating during the pandemic. As social distancing and remote working became the new...